Skip to main content
SpringerLink
Log in

Progression or reactivation of Otosclerotic lesion despite Fluoride therapy

  • Original Articles
  • Published:
Indian Journal of Otolaryngology Aims and scope Submit manuscript

Abstract

Progression or reactivation of Otosclerotic disease as shown by tomography, despitemoderate dosage Sodium Fluoride therapy, is due to poor intestinal absorption of the drug in its enteric coated form. It is also seen when the drug is often temporarily withdrawn. During Sodium Fluoride therapy for Otosclerosis an intestinal absorption test of the preparation is necessary.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Deka, R.C., Kacker S.K., Shambaugh G.E., Jr. (1978): Intestinal absorption of Fluoride-Laryngoscope 88: 1918–1921.

    Article  PubMed  CAS  Google Scholar 

  2. Shambaugh G.E. Jr. & Petrovic, A., (1968): Effects of Sodium Flouride on bone:An application to Otosclerosis and other declacifying bone diseases.Journal of the American Medical Association.204: 967.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otolaryngology, J.I.P.M.E.R., Pondicherry

    R. C. Deka

Authors
  1. R. C. Deka
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Deka, R.C. Progression or reactivation of Otosclerotic lesion despite Fluoride therapy. Indian J Otolaryngol 31, 101–102 (1979). https://doi.org/10.1007/BF02992405

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02992405

Keywords

Search

Navigation